218 related articles for article (PubMed ID: 34190188)
1. Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study.
Oguz A; Sahin M; Tuzun D; Kurutas EB; Ulgen C; Bozkus O; Gul K
Medicine (Baltimore); 2021 Jul; 100(26):e26529. PubMed ID: 34190188
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Fat Mass Index and Fat Free Mass Index With Body Mass Index and Association With Function, Cognition and Sarcopenia in Pre-Frail Older Adults.
Merchant RA; Seetharaman S; Au L; Wong MWK; Wong BLL; Tan LF; Chen MZ; Ng SE; Soong JTY; Hui RJY; Kwek SC; Morley JE
Front Endocrinol (Lausanne); 2021; 12():765415. PubMed ID: 35002957
[TBL] [Abstract][Full Text] [Related]
3. Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
García-Fontana B; Reyes-García R; Morales-Santana S; Ávila-Rubio V; Muñoz-Garach A; Rozas-Moreno P; Muñoz-Torres M
Endocrine; 2016 Apr; 52(1):54-62. PubMed ID: 26438394
[TBL] [Abstract][Full Text] [Related]
4. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
5. Identification of sarcopenic obesity in adults undergoing orthopaedic surgery: Relationship between "a body shape index" (ABSI) and fat-free mass. A cross -sectional study.
Tomažič A; Žvanut B; Grbac LV; Jurdana M
PLoS One; 2022; 17(6):e0269956. PubMed ID: 35731798
[TBL] [Abstract][Full Text] [Related]
6. Association of serum adiponectin and myostatin levels with skeletal muscle in patients with obesity: A cross-sectional study.
Kurose S; Onishi K; Takao N; Miyauchi T; Takahashi K; Kimura Y
PLoS One; 2021; 16(1):e0245678. PubMed ID: 33465151
[TBL] [Abstract][Full Text] [Related]
7. Fat and fat-free mass as important determinants of body composition assessment in relation to sarcopenic obesity.
Gažarová M; Bihari M; Šoltís J
Rocz Panstw Zakl Hig; 2023; 74(1):59-69. PubMed ID: 37010407
[TBL] [Abstract][Full Text] [Related]
8. Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk.
Bonfante ILP; Chacon-Mikahil MPT; Brunelli DT; Gáspari AF; Duft RG; Oliveira AG; Araujo TG; Saad MJA; Cavaglieri CR
Arch Endocrinol Metab; 2017 Dec; 61(6):524-533. PubMed ID: 29412381
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and associations of sarcopenia, obesity and sarcopenic obesity in end-stage knee osteoarthritis patients.
Liao J; Chen J; Xu W; Chen J; Liang X; Cheng Q; Tang Y; Huang W
J Health Popul Nutr; 2023 Oct; 42(1):108. PubMed ID: 37833797
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of sarcopenic obesity and association with metabolic syndrome in an adult Iranian cohort: The Fasa PERSIAN cohort study.
Siervo M; Rubele S; Shannon OM; Prado CM; Donini LM; Zamboni M; Homayounfar R; Farjam M; Faghih S; Mazidi M
Clin Obes; 2021 Aug; 11(4):e12459. PubMed ID: 33946126
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
[TBL] [Abstract][Full Text] [Related]
12. Inverse relationship between "a body shape index" (ABSI) and fat-free mass in women and men: Insights into mechanisms of sarcopenic obesity.
Biolo G; Di Girolamo FG; Breglia A; Chiuc M; Baglio V; Vinci P; Toigo G; Lucchin L; Jurdana M; Pražnikar ZJ; Petelin A; Mazzucco S; Situlin R
Clin Nutr; 2015 Apr; 34(2):323-7. PubMed ID: 24814384
[TBL] [Abstract][Full Text] [Related]
13. Role of irisin and myostatin on sarcopenia in malnourished patients diagnosed with GLIM criteria.
de Luis D; Primo D; Izaola O; Gómez JJL
Nutrition; 2024 Apr; 120():112348. PubMed ID: 38309190
[TBL] [Abstract][Full Text] [Related]
14. Myokines in Acromegaly: An Altered Irisin Profile.
Mizera Ł; Halupczok-Żyła J; Kolačkov K; Zembska A; Grzegrzółka J; Jędrzejuk D; Bolanowski M; Daroszewski J
Front Endocrinol (Lausanne); 2021; 12():728734. PubMed ID: 34795636
[TBL] [Abstract][Full Text] [Related]
15. The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype.
Hwang YC; Jeon WS; Park CY; Youn BS
Cardiovasc Diabetol; 2016 Jan; 15():9. PubMed ID: 26790404
[TBL] [Abstract][Full Text] [Related]
16. [The prevalence of sarcopenic obesity in postmenopausal women in depending on the used methodology - preliminary study].
Milewska M; Sińska B; Sych D; Kucharska A
Pol Merkur Lekarski; 2015 Apr; 38(226):206-10. PubMed ID: 25938387
[TBL] [Abstract][Full Text] [Related]
17. Body composition indices of a load-capacity model: gender- and BMI-specific reference curves.
Siervo M; Prado CM; Mire E; Broyles S; Wells JC; Heymsfield S; Katzmarzyk PT
Public Health Nutr; 2015 May; 18(7):1245-54. PubMed ID: 25221994
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenic Obesity in Chronic Kidney Disease: Challenges in Diagnosis Using Different Diagnostic Criteria.
Bellafronte NT; de Queirós Mattoso Ono A; Chiarello PG
Med Princ Pract; 2021; 30(5):477-486. PubMed ID: 34082433
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenic obesity is associated with macroalbuminuria in patients with type 2 diabetes: a cross-sectional study.
Takahashi F; Hashimoto Y; Kaji A; Sakai R; Okamura T; Hamaguchi M; Fukui M
Endocr J; 2021 Jul; 68(7):781-789. PubMed ID: 33731539
[TBL] [Abstract][Full Text] [Related]
20. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study.
Sahin-Efe A; Upadhyay J; Ko BJ; Dincer F; Park KH; Migdal A; Vokonas P; Mantzoros C
Metabolism; 2018 Feb; 79():24-32. PubMed ID: 29108900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
